Abstract:The cell cycle is the sequence of events orchestrated by a complex network of cell cycle proteins. Unlike normal cells, mature neurons subsist in a quiescent state of the cell cycle, and aberrant cell cycle activation triggers neuronal death accompanied by neurodegeneration. The periodicity of cell cycle events is choreographed by various mechanisms, including DNA damage repair, oxidative stress, neurotrophin activity, and ubiquitin-mediated degradation. Given the relevance of cell cycle processes in cancer and neurodegeneration, this review delineates the overlapping cell cycle events, signaling pathways, and mechanisms associated with cell cycle aberrations in cancer and the major neurodegenerative disorders. We suggest that dysregulation of some common fundamental signaling processes triggers anomalous cell cycle activation in cancer cells and neurons. We discussed the possible use of cell cycle inhibitors for neurodegenerative disorders and described the associated challenges. We propose that a greater understanding of the common mechanisms driving cell cycle aberrations in cancer and neurodegenerative disorders will open a new avenue for the development of repurposed drugs.Graphical AbstractCell cycle activation and cell cycle re-entry are the two critical cellular phenomena associated with cancer and neurodegeneration, respectively. Various regulatory proteins, such as cyclin-dependent kinases (CDKs), cyclins, and checkpoint kinases, control the cell cycle dynamics at different phases. Further, the integrity of cell cycle is controlled by different mechanisms like DNA damage response, oxidative stress, neurotrophin activity, and the ubiquitin–proteasome system (UPS), the alterations which play an essential role in the pathogenesis of both cancer and neurodegenerative disorders. Pharmacological targeting of important cell cycle regulatory molecules like the application of CDK inhibitors, PARP inhibitors, checkpoint kinase inhibitors, and microtubule inhibitors holds great promise for treating various human cancers and can be repurposed for different neurodegenerative disorders.

Cell cycle regulation and neural differentiation

Extra-cell cycle regulatory functions of cyclin-dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disorders

Cell cycle regulation of neuronal apoptosis in development and disease

Cell Cycle Regulation and Hematologic Malignancies

Cell Cycle Re-entry in the Nervous System: From Polyploidy to Neurodegeneration

A Unilateral Negative Feedback Loop Between Mir-200 Micrornas And Sox2/E2f3 Controls Neural Progenitor Cell-Cycle Exit And Differentiation

Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs

Neuronal cell cycle: the neuron itself and its circumstances

Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer.

A low CDKN1c/p57kip2 expression in spinal progenitors drives the transition from proliferative to neurogenic modes of division

A Review of the Regulatory Mechanisms of N-Myc on Cell Cycle

Cell Cycle Regulation Through Primary Cilium: A Long-Forgotten Story

CDK7 and Mir-210 Co-regulate Cell-Cycle Progression of Neural Progenitors in the Developing Neocortex

The Role of the Interaction of p53 and the MAPK Cascade in Controlling Neuronal Differentiation in the PC12 Cell Line

The Cdk1 complex plays a prime role in regulating N-myc phosphorylation and turnover in neural precursors

Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System

The Control of Cell Cycle in Mouse Primordial Germ Cells: Old and New Players

Cooperation Between The Cdk Inhibitors P27(Kip1) And P57(Kip2) In The Control Of Tissue Growth And Development

Concise Review: Control of Cell Fate Through Cell Cycle and Pluripotency Networks

Novel insights into cell cycle regulation of cell fate determination

Cell Cycle Regulation of Stem Cells by MicroRNAs